DNA Sequence SRL Hellas is pleased to announce the extension of the ISO 17025:2017 accreditation of its laboratory services, further strengthening the scope and reliability of the analyses it provides in the field of metagenomics and molecular identification of microorganisms.
This new extension covers additional sample types, including wastewater and upper respiratory clinical samples, substantially expanding the application of our accredited methods in areas of high importance for public health, epidemiological surveillance, and clinical practice.
This development complements the company’s already accredited work in the analysis of environmental samples such as surfaces, air, soil, and water, confirming its ongoing investment in quality, scientific validation, and technological innovation.
ISO 17025 accreditation ensures that all analyses are performed according to internationally recognized standards of quality, accuracy, and reproducibility, enhancing the reliability of results and their value in decision-making by healthcare organizations, research institutions, and partner organizations.
With this extension, DNA Sequence SRL Hellas further strengthens its role as a pioneer in the fields of metagenomics and bioinformatics, now offering accredited solutions for an even broader range of applications — from environmental surveillance to clinical detection and the study of antimicrobial resistance.
This achievement is the result of the systematic work and high level of expertise of the company’s team, as well as the trust of its partners and clients, and marks another step toward strengthening DNA Sequence SRL Hellas’ scientific and technological contribution to public health and microbial analysis.
